What's in Mirati Therapeutics Inc.'s pipeline?

Mirati Therapeutics Inc. has 4 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with Mirati Therapeutics Inc.'s portfolio?

Top competitors by shared drug class: Astellas Pharma Global Development, Inc., Children's Cancer Group, China, Copharos, Criterium, Inc., Dark Canyon Laboratories, LLC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/mirati-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Mirati Therapeutics Inc. — Portfolio Competitive Intelligence Brief

Mirati Therapeutics Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
MRTX849	MRTX849	phase 3	KRAS G12C inhibitor	KRAS G12C	Oncology

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Astellas Pharma Global Development, Inc. · 1 shared drug class
Children's Cancer Group, China · 1 shared drug class
Copharos · 1 shared drug class
Criterium, Inc. · 1 shared drug class
Dark Canyon Laboratories, LLC · 1 shared drug class
Eastern Cooperative Oncology Group · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Mirati Therapeutics Inc.:

Cite this brief

Drug Landscape (2026). Mirati Therapeutics Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/mirati-therapeutics-inc. Accessed 2026-05-16.